Monitor for further board departures or potential activist interest given the ongoing turnover. The annual meeting outcome is unlikely to be materially affected, but the lack of a replacement nominee may signal difficulty in attracting qualified directors.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 9 $8.50entry
- T+1 · 5mo ago −0.94%α +0.64% · $8.42
- T+5 · 5mo ago +2.24%α −0.18% · $8.69
- T+20 · 4mo ago +5.76%α +4.32% · $8.99
- T+60 · 3mo ago +50.84%α +47.02% · $12.82
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
American Well filed a DEFA14A supplement to its 2026 proxy statement, announcing that co-founder Dr. Roy Schoenberg will not stand for re-election as a Class III director at the annual meeting and that the board will not nominate a substitute. This follows his recent resignation from the board on May 6, 2026, and the earlier resignation of director Dr. Peter Slavin, continuing a pattern of board turnover at the $146M market cap telehealth company.
Key Financial Metrics
Key Facts
- Dr. Roy Schoenberg, co-founder and former Executive Vice Chairman, will not stand for re-election as a Class III director at the 2026 annual meeting.
- The board will not nominate a substitute candidate for the vacant seat.
- Votes cast on Schoenberg's re-election proposal will not be counted.
- This follows Schoenberg's resignation from the board on May 6, 2026, and the earlier resignation of director Dr. Peter Slavin.
- The supplement updates the definitive proxy statement filed April 23, 2026.
Financial Impact
No direct financial impact; board composition change at a $146M market cap company with no substitute nominee.
Risk Factors
- Continued board departures could signal governance instability or internal disagreements.
- No substitute nominee may reduce board diversity or expertise, potentially impacting strategic oversight.
- Shareholder dissatisfaction could emerge if the board fails to fill vacancies promptly.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0000950103-26-008695 |
| Document: 0000950103-26-008695-index-headers.html | 0000950103-26-008695 |
| Document: 0000950103-26-008695-index.html | 0000950103-26-008695 |
| Document: 0000950103-26-008695.txt | 0000950103-26-008695 |
Track record
18 reports on AMWL
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 13, 20263d ago DEFA14A Neutral 3/10 Entry $11.74 Now $11.34 −3.41% settles Feb 11
- Nov 13, 20263d ago DEF 14A Neutral 3/10 Entry $11.74 Now $11.34 −3.41% settles Feb 11
- Nov 3, 202613d ago 8-K Neutral 5/10 Entry $12.35 Now $11.34 −8.18% settles Feb 2
- Oct 5, 20266w ago Insider Cluster Neutral 3/10 Entry $12.27 Now $11.34 −7.58% settles Dec 31
- Oct 1, 20266w ago 144 Neutral 2/10 Entry $12.39 Now $11.34 −8.47% settles Dec 29
- Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $12.99 Now $11.34 −12.70% settles Dec 1
- Aug 4, 202614w ago 8-K Mixed 6/10 Entry $13.02 to $14.91 Now $11.34 −12.90% ▲ +14.52% +14.32% vs SPY
- Jul 1, 202619w ago Insider Cluster Neutral 2/10 Entry $9.25 to $13.44 Now $11.34 +22.59% ▲ +45.30% +42.50% vs SPY
- Jul 1, 202619w ago 144 Neutral 2/10 Entry $9.25 to $13.47 Now $11.34 +22.59% ▲ +45.62% +42.61% vs SPY
- Jun 9, 202622w ago DEFA14A Neutral 3/10 Viewing Entry $8.50 to $12.82 Now $11.34 +33.41% ▲ +50.84% +47.02% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers